Skip to main content
Top
Published in: Pediatric Drugs 5/2012

01-10-2012 | Original Research Article

Adherence to Antiretroviral Therapy in HIV-Positive Adolescents in Uganda Assessed by Multiple Methods

A Prospective Cohort Study

Authors: Dr Matthew O. Wiens, Stuart MacLeod, Victor Musiime, Mark Ssenyonga, Ruth Kizza, Sabrina Bakeera-Kitaka, Richard Odoi-Adome, Francis Ssali

Published in: Pediatric Drugs | Issue 5/2012

Login to get access

Abstract

Background

The effectiveness of traditional adherence measurements used in adolescent populations is difficult to assess. Antiretroviral (ARV) adherence research among adolescents living with HIV in resource-constrained countries is particularly challenging and little evidence is available.

Objectives

The primary objective of this study was to determine the feasibility of a large-scale, long-term study using electronic adherence monitoring in Uganda. The secondary objective was to compare accuracy of pill count (PC) and self-report (SR) adherence with electronic medication vials (eCAPs™).

Methods

Adolescents receiving ARV therapy at the Joint Clinical Research Centre in Kampala, Uganda, were recruited. ARVs were dispensed in eCAPs™ for 1 year. Person-pill-days (PPDs) [1 day where adherence was measured for one medication in one patient] were calculated and a weighted paired t-test was used to compare the levels of adherence among subjects for three different adherence measurement methods.

Results

Fifteen patients were included: 40% were female, mean age was 14 years, mean baseline CD4+ cell count was 244 cells/μL, and average treatment duration was 9 months at study entry. Overall, 4721 PPDs were observed. Some eCAPs™ required replacement during the study resulting in some data loss. Consent rate was high (94%) but was slow due to age limit cut-points.
Overall adherence for SR was 99%, PC was 97% and eCAP™ was 88% (p<0.05 for all comparisons). 93%, 67% and 23% of patients had an adherence of greater than 95% as measured by SR, PC and eCAP™ methods, respectively.

Conclusions

A large-scale adherence study in Uganda would be feasible using a more robust electronic monitoring system. Adherence measurements produced by PCs and self-reporting methods appear to overestimate adherence measured electronically.
Literature
1.
go back to reference Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep 2009; 6 (4): 194–200.PubMedCrossRef Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep 2009; 6 (4): 194–200.PubMedCrossRef
2.
go back to reference Biadgilign S, Deribew A, Amberbir A, et al. Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia. BMC Pediatr 2008; 8: 53.PubMedCrossRef Biadgilign S, Deribew A, Amberbir A, et al. Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia. BMC Pediatr 2008; 8: 53.PubMedCrossRef
3.
go back to reference Davies MA, Boulle A, Fakir T, et al. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr 2008; 8: 34.PubMedCrossRef Davies MA, Boulle A, Fakir T, et al. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr 2008; 8: 34.PubMedCrossRef
4.
go back to reference Müller AD, Bode S, Myer L, et al. Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatr Infect Dis J 2008; 27 (3): 257–62.PubMedCrossRef Müller AD, Bode S, Myer L, et al. Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatr Infect Dis J 2008; 27 (3): 257–62.PubMedCrossRef
5.
go back to reference Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009; 51 (1): 65–71.PubMedCrossRef Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009; 51 (1): 65–71.PubMedCrossRef
6.
go back to reference Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PloS One 2011; 6 (4): e19261.PubMedCrossRef Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PloS One 2011; 6 (4): e19261.PubMedCrossRef
7.
go back to reference Twagirumukiza M, Kayumba PC, Kips JG, et al. Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malaria J 2010; 9: 206.CrossRef Twagirumukiza M, Kayumba PC, Kips JG, et al. Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malaria J 2010; 9: 206.CrossRef
8.
go back to reference Bell DJ, Kapitao Y, Sikwese R, et al. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr 2007; 45 (5): 560–3.PubMedCrossRef Bell DJ, Kapitao Y, Sikwese R, et al. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr 2007; 45 (5): 560–3.PubMedCrossRef
9.
go back to reference Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006; 10 (4 Suppl.): S85–93.PubMedCrossRef Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006; 10 (4 Suppl.): S85–93.PubMedCrossRef
10.
go back to reference Martin S, Elliott-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatric Infect Dis J 2007; 26 (1): 61–7.CrossRef Martin S, Elliott-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatric Infect Dis J 2007; 26 (1): 61–7.CrossRef
11.
go back to reference Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, et al. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr 2007; 27 (2): 123–31.PubMedCrossRef Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, et al. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr 2007; 27 (2): 123–31.PubMedCrossRef
12.
go back to reference Bärnighausen T, Chaiyachati K, Chimbindi N, et al. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 3099 (11): 1–10. Bärnighausen T, Chaiyachati K, Chimbindi N, et al. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 3099 (11): 1–10.
13.
go back to reference Bisson GP, Rowh A, Weinstein R, et al. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr 2008; 49 (1): 107–10.PubMedCrossRef Bisson GP, Rowh A, Weinstein R, et al. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr 2008; 49 (1): 107–10.PubMedCrossRef
Metadata
Title
Adherence to Antiretroviral Therapy in HIV-Positive Adolescents in Uganda Assessed by Multiple Methods
A Prospective Cohort Study
Authors
Dr Matthew O. Wiens
Stuart MacLeod
Victor Musiime
Mark Ssenyonga
Ruth Kizza
Sabrina Bakeera-Kitaka
Richard Odoi-Adome
Francis Ssali
Publication date
01-10-2012
Publisher
Springer International Publishing
Published in
Pediatric Drugs / Issue 5/2012
Print ISSN: 1174-5878
Electronic ISSN: 1179-2019
DOI
https://doi.org/10.1007/BF03262238

Other articles of this Issue 5/2012

Pediatric Drugs 5/2012 Go to the issue